Cargando…
Potential New Non-Invasive Therapy Using Artificial Oxygen Carriers for Pre-Eclampsia
The molecular mechanisms of pre-eclampsia are being increasingly clarified in animals and humans. With the uncovering of these mechanisms, preventive therapy strategies using chronic infusion of adrenomedullin, vascular endothelial growth factor-121 (VEGF-121), losartan, and sildenafil have been pro...
Autores principales: | Ohta, Hidenobu, Kaga, Maiko, Li, Heng, Sakai, Hiromi, Okamura, Kunihiro, Yaegashi, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618283/ https://www.ncbi.nlm.nih.gov/pubmed/28758949 http://dx.doi.org/10.3390/jfb8030032 |
Ejemplares similares
-
Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model
por: Li, Heng, et al.
Publicado: (2015) -
The Pre-Eclampsia Ontology: A Disease Ontology Representing the Domain Knowledge Specific to Pre-Eclampsia
por: Mizuno, Satoshi, et al.
Publicado: (2016) -
The Relationship between Obesity and Pre-Eclampsia: Incidental Risks and Identification of Potential Biomarkers for Pre-Eclampsia
por: Abraham, Talitha, et al.
Publicado: (2022) -
MBL Interferes with Endovascular Trophoblast Invasion in Pre-Eclampsia
por: Agostinis, Chiara, et al.
Publicado: (2012) -
Cardiac involvement in pre-eclampsia and eclampsia syndrome
por: Andraos, A, et al.
Publicado: (2004)